vs
百济神州（ONC）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
百济神州的季度营收约是Rollins, Inc.的1.7倍（$1.5B vs $906.4M），Rollins, Inc.净利率更高（11.9% vs 4.4%，领先7.5%），百济神州同比增速更快（32.8% vs 10.2%），百济神州自由现金流更多（$379.8M vs $111.2M），过去两年百济神州的营收复合增速更高（41.2% vs 0.8%）
BeOne Medicines（原百济神州）是一家跨国肿瘤领域制药企业，专注于癌症治疗创新药物的研发与商业化，致力于为全球癌症患者提供更有效、可及性更高的治疗方案，改善患者的生存质量与预后。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
ONC vs ROL — 直观对比
营收规模更大
ONC
是对方的1.7倍
$906.4M
营收增速更快
ONC
高出22.6%
10.2%
净利率更高
ROL
高出7.5%
4.4%
自由现金流更多
ONC
多$268.6M
$111.2M
两年增速更快
ONC
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $906.4M |
| 净利润 | $66.5M | $107.8M |
| 毛利率 | 90.5% | — |
| 营业利润率 | 12.4% | 16.1% |
| 净利率 | 4.4% | 11.9% |
| 营收同比 | 32.8% | 10.2% |
| 净利润同比 | 143.8% | 2.5% |
| 每股收益（稀释后） | $0.05 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ONCROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.5B | $912.9M | ||
| Q3 25 | $1.4B | $1.0B | ||
| Q2 25 | $1.3B | $999.5M | ||
| Q1 25 | $1.1B | $822.5M | ||
| Q4 24 | $1.1B | $832.2M | ||
| Q3 24 | $1.0B | $916.3M | ||
| Q2 24 | $929.2M | $891.9M |
净利润ONCROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $66.5M | $116.4M | ||
| Q3 25 | $124.8M | $163.5M | ||
| Q2 25 | $94.3M | $141.5M | ||
| Q1 25 | $1.3M | $105.2M | ||
| Q4 24 | $-151.9M | $105.7M | ||
| Q3 24 | $-121.3M | $136.9M | ||
| Q2 24 | $-120.4M | $129.4M |
毛利率ONCROL
| Q1 26 | — | — | ||
| Q4 25 | 90.5% | — | ||
| Q3 25 | 86.1% | — | ||
| Q2 25 | 87.5% | — | ||
| Q1 25 | 85.2% | — | ||
| Q4 24 | 85.8% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 85.1% | — |
营业利润率ONCROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 12.4% | 17.5% | ||
| Q3 25 | 11.5% | 21.9% | ||
| Q2 25 | 6.7% | 19.8% | ||
| Q1 25 | 1.0% | 17.3% | ||
| Q4 24 | -7.0% | 18.1% | ||
| Q3 24 | -12.0% | 20.9% | ||
| Q2 24 | -11.5% | 20.4% |
净利率ONCROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | 4.4% | 12.8% | ||
| Q3 25 | 8.8% | 15.9% | ||
| Q2 25 | 7.2% | 14.2% | ||
| Q1 25 | 0.1% | 12.8% | ||
| Q4 24 | -13.5% | 12.7% | ||
| Q3 24 | -12.1% | 14.9% | ||
| Q2 24 | -13.0% | 14.5% |
每股收益（稀释后）ONCROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $0.05 | $0.24 | ||
| Q3 25 | $0.08 | $0.34 | ||
| Q2 25 | $0.06 | $0.29 | ||
| Q1 25 | $0.00 | $0.22 | ||
| Q4 24 | $-0.10 | $0.22 | ||
| Q3 24 | $-0.09 | $0.28 | ||
| Q2 24 | $-0.09 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $116.5M |
| 总债务越低越好 | $836.4M | $650.6M |
| 股东权益账面价值 | $4.4B | $1.4B |
| 总资产 | $8.2B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资ONCROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $4.5B | $100.0M | ||
| Q3 25 | $4.0B | $127.4M | ||
| Q2 25 | $2.8B | $123.0M | ||
| Q1 25 | $2.5B | $201.2M | ||
| Q4 24 | $2.6B | $89.6M | ||
| Q3 24 | $2.7B | $95.3M | ||
| Q2 24 | $2.6B | $106.7M |
总债务ONCROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | $836.4M | $486.1M | ||
| Q3 25 | — | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ONCROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $4.4B | $1.4B | ||
| Q3 25 | $4.1B | $1.5B | ||
| Q2 25 | $3.8B | $1.4B | ||
| Q1 25 | $3.5B | $1.4B | ||
| Q4 24 | $3.3B | $1.3B | ||
| Q3 24 | $3.4B | $1.3B | ||
| Q2 24 | $3.4B | $1.2B |
总资产ONCROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $8.2B | $3.1B | ||
| Q3 25 | $7.6B | $3.2B | ||
| Q2 25 | $6.3B | $3.2B | ||
| Q1 25 | $5.8B | $2.9B | ||
| Q4 24 | $5.9B | $2.8B | ||
| Q3 24 | $5.8B | $2.8B | ||
| Q2 24 | $5.7B | $2.8B |
负债/权益比ONCROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | 0.19× | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $417.3M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $379.8M | $111.2M |
| 自由现金流率自由现金流/营收 | 25.4% | 12.3% |
| 资本支出强度资本支出/营收 | 2.5% | 0.8% |
| 现金转化率经营现金流/净利润 | 6.28× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $941.7M | $621.1M |
8季度趋势，按日历期对齐
经营现金流ONCROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $417.3M | $164.7M | ||
| Q3 25 | $402.6M | $191.3M | ||
| Q2 25 | $263.6M | $175.1M | ||
| Q1 25 | $44.1M | $146.9M | ||
| Q4 24 | $75.2M | $188.2M | ||
| Q3 24 | $188.4M | $146.9M | ||
| Q2 24 | $-95.6M | $145.1M |
自由现金流ONCROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $379.8M | $159.0M | ||
| Q3 25 | $354.5M | $182.8M | ||
| Q2 25 | $219.8M | $168.0M | ||
| Q1 25 | $-12.3M | $140.1M | ||
| Q4 24 | $-17.3M | $184.0M | ||
| Q3 24 | $54.7M | $139.4M | ||
| Q2 24 | $-205.5M | $136.4M |
自由现金流率ONCROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 25.4% | 17.4% | ||
| Q3 25 | 25.1% | 17.8% | ||
| Q2 25 | 16.7% | 16.8% | ||
| Q1 25 | -1.1% | 17.0% | ||
| Q4 24 | -1.5% | 22.1% | ||
| Q3 24 | 5.5% | 15.2% | ||
| Q2 24 | -22.1% | 15.3% |
资本支出强度ONCROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 2.5% | 0.6% | ||
| Q3 25 | 3.4% | 0.8% | ||
| Q2 25 | 3.3% | 0.7% | ||
| Q1 25 | 5.0% | 0.8% | ||
| Q4 24 | 8.2% | 0.5% | ||
| Q3 24 | 13.3% | 0.8% | ||
| Q2 24 | 11.8% | 1.0% |
现金转化率ONCROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 6.28× | 1.41× | ||
| Q3 25 | 3.22× | 1.17× | ||
| Q2 25 | 2.79× | 1.24× | ||
| Q1 25 | 34.71× | 1.40× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
